Kharwar has previously held significant positions at FDC , Johnson & Johnson (J&J), and MSD/Merck
Read More
More than 50 greenfield pharmaceutical and medical device plants have already been completed under the scheme, catalysing exports worth USD 10 billion to countries with the highest regulatory standards
Read More
Globally, 90per cent of blindness is preventable or treatable, yet over 1 billion people are living with some form of vision loss. The global economic burden of vision impairment was estimated at $410.9 billion (about $1,300 per person in the US) in 2020 alone.
Read More
The Drug Controller General of India (DCGI) has suspended the authorisation granted to Mumbai-based Entod Pharmaceuticals to manufacture and market its eye drops, citing unapproved claims made by the company regarding its effectiveness in reducing dependence on reading glasses for individuals with presbyopia.
Read More
Medhekar will report directly to Mr. Sanjeev Jain and Mr. Sandeep Jain, the Joint Managing Directors of Akums.
Read More
Additionally, it has received tentative approval for the 137 mg dosage strength
Read More_20240819184310_original_image_20.webp)
The introduction of this new ophthalmic solution comes in response to a growing demand for additional suppliers in the OTC eye care market
Read More
Trazodone tablets are prescribed for the treatment of major depressive disorder in adults
Read More
This marks Quadria's second pharmaceutical exit via IPO in India within the past year
Read More
To develop sustainable strategies, the FY25 has witnessed a 12.9 per cent increase from the revised estimate of Rs.80,517.62 crore
Read More
